Loading...

Free Cash Flow Build Up

Illumina Inc.

Illumina Inc. (ILMN)

Healthcare

Year
A/P
2013
Actual
2014
Actual
2015
Projected
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue 1,421.181,861.322,437.773,192.744,181.545,476.567,172.659,394.0212,303.3416,113.6921,104.10
EBITDA 268.32665.42665.75871.941,141.981,495.651,958.852,565.513,360.044,400.655,763.53
EBIT 134.16514.84451.96591.93775.261,015.351,329.811,741.652,281.042,987.483,912.70
Tax Rate 333.34%21.26%177.30%20.85%30.39%7.61%82.69%82.69%82.69%82.69%82.69%
EBIAT -313.04405.3878.24468.52539.63938.12230.20301.50394.87517.17677.33
Depreciation 134.16150.58213.79280.00366.72480.29629.04823.861,079.001,413.171,850.83
Accounts Receivable --50.53-105.00-122.16-159.99-209.53-274.43-359.42-470.73-616.51-807.45
Inventories --37.10-66.27-79.73-104.42-136.75-179.11-234.58-307.22-402.37-526.99
Accounts Payable -9.0334.6136.3147.5662.2981.58106.85139.94183.28240.04
Capital Expenditure --26.75-31.34-42.51-55.67-72.91-95.49-125.06-163.80-214.52-280.96
UFCF -178.88450.60124.04540.45633.841,061.51391.80513.15672.07880.201,152.80
WACC
PV UFCF 124.04540.45633.841,061.51391.80513.15672.07880.201,152.80
SUM PV UFCF 6,241.59